Cargando…

Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A(2A) receptor

Biased agonism, the ability of agonists to differentially activate downstream signaling pathways by stabilizing specific receptor conformations, is a key issue for G protein-coupled receptor (GPCR) signaling. The C-terminal domain might influence this functional selectivity of GPCRs as it engages G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Gemma, Gonzalez, Angel, Campanacci, Stefano, Rivas-Santisteban, Rafael, Reyes-Resina, Irene, Casajuana-Martin, Nil, Cordomí, Arnau, Pardo, Leonardo, Franco, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550916/ https://www.ncbi.nlm.nih.gov/pubmed/33101610 http://dx.doi.org/10.1016/j.csbj.2020.09.028

Ejemplares similares

The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions
por: Franco, Rafael, et al.
Publicado: (2021)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
por: Franco, Rafael, et al.
Publicado: (2021)

Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells
por: Franco, Rafael, et al.
Publicado: (2021)

Antagonization of OX(1) Receptor Potentiates CB(2) Receptor Function in Microglia from APP(Sw/Ind) Mice Model
por: Raïch, Iu, et al.
Publicado: (2022)

Biased agonism
por: Kenakin, Terry
Publicado: (2009)

Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage
por: Franco, Rafael, et al.
Publicado: (2021)

Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters
por: Franco, Rafael, et al.
Publicado: (2021)

Adenosine A(2A) Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Adenosine A(2A) and A(3) Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling
por: Lillo, Alejandro, et al.
Publicado: (2020)

Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1
por: Sanchez, Julie, et al.
Publicado: (2019)

Molecular Vibration-Activity Relationship in the Agonism of Adenosine Receptors
por: Chee, Hyun Keun, et al.
Publicado: (2013)

Cooh-Terminal Truncated Alpha(1S) Subunits Conduct Current Better than Full-Length Dihydropyridine Receptors
por: Morrill, James A., et al.
Publicado: (2000)

A Pharmacological Primer of Biased Agonism
por: Andresen, Bradley T
Publicado: (2011)

Methamphetamine Blocks Adenosine A(2A) Receptor Activation via Sigma 1 and Cannabinoid CB(1) Receptors
por: Casanovas, Mireia, et al.
Publicado: (2021)

Biased agonism: the quest for the analgesic holy grail
por: Stanczyk, M. Alexander, et al.
Publicado: (2018)

Angiotensin AT(1) and AT(2) receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2020)

Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
por: Franco, Rafael, et al.
Publicado: (2020)

Co-expression of truncated and full-length tau induces severe neurotoxicity
por: Ozcelik, S, et al.
Publicado: (2016)

Characterization of RNA driven structural changes in full length RIG-I leading to its agonism or antagonism
por: Sikorska, Justyna, et al.
Publicado: (2023)

Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
por: Ali, Ramadan A., et al.
Publicado: (2019)

The role of kinetic context in apparent biased agonism at GPCRs
por: Klein Herenbrink, Carmen, et al.
Publicado: (2016)

The therapeutic potential of GLP‐1 receptor biased agonism
por: Jones, Ben
Publicado: (2021)

A structural mechanism of nuclear receptor biased agonism
por: Nemetchek, Michelle D., et al.
Publicado: (2022)

Characterization of Full-Length and Truncated Recombinant κ-Carrageenase Expressed in Pichia pastoris
por: Yu, Yuan, et al.
Publicado: (2017)

Pleiotrophin Gene Therapy for Peripheral Ischemia: Evaluation of Full-Length and Truncated Gene Variants
por: Fang, Qizhi, et al.
Publicado: (2013)

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
por: Azevedo Neto, Joaquim, et al.
Publicado: (2020)

Ligand recognition and biased agonism of the D1 dopamine receptor
por: Teng, Xiao, et al.
Publicado: (2022)

Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2014)

Cross-communication between G(i) and G(s) in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
por: Navarro, Gemma, et al.
Publicado: (2018)

Heterologous Expression of Full-Length and Truncated Human ZIP4 Zinc Transporter in Saccharomyces cerevisiae
por: Liu, Yuting, et al.
Publicado: (2022)

A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses
por: Burgueño, Javier, et al.
Publicado: (2017)

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons
por: Franco, Rafael, et al.
Publicado: (2023)

A Single Point Mutation Blocks the Entrance of Ligands to the Cannabinoid CB(2) Receptor via the Lipid Bilayer
por: Casajuana-Martin, Nil, et al.
Publicado: (2022)

Pre-Steady-State Kinetic Analysis of Truncated and Full-Length Saccharomyces cerevisiae DNA Polymerase Eta
por: Brown, Jessica A., et al.
Publicado: (2010)

Control of glutamate release by complexes of adenosine and cannabinoid receptors
por: Köfalvi, Attila, et al.
Publicado: (2020)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB(2) Receptor
por: Morales, Paula, et al.
Publicado: (2020)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022)

Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2016)

A Practical Guide to Approaching Biased Agonism at G Protein Coupled Receptors
por: Gundry, Jaimee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pe2iqivbnlk4kh50d54mkcdktl